Posted by Patienceandwin > 2021-05-25 00:17 | Report Abuse

Zhifei vaccine no update ka

Posted by OnTime > 2021-05-25 08:53 | Report Abuse

maybe dogs can id covid but i'm sure the suspect will still have to be tested, no? zhifei vaccine has been granted eua in china but not yet approved in m'sia.

Posted by Tradewolf33 > 2021-05-25 15:21 | Report Abuse

i don't think doggie concept will apply in Malaysia Gov

Posted by collie > 2021-05-27 12:20 | Report Abuse

slowly climbing up

Posted by Brucehwang > 2021-05-27 18:23 | Report Abuse

Why went the price up in the last minite?

Posted by Flyingback > 2021-05-27 18:28 | Report Abuse

There is speculation tht the Breathonix test is going to b offered or implemented in Malaysia

Posted by gohkimhock > 2021-05-27 18:34 | Report Abuse

if Singapore is using it widely, i don't see any reasons why Malaysia is holding it up..

Posted by OnTime > 2021-05-27 19:59 | Report Abuse

this simple, fast, cheap, and effective test is a big deal for myeg!

Posted by collie > 2021-05-27 22:41 | Report Abuse

portfolio rebalancing mate. and agree, it can be useful for airport screening,

Posted by DreamHunter > 2021-05-27 22:51 | Report Abuse

ha ha ha

Posted by DreamHunter > 2021-05-27 22:51 | Report Abuse

yah kah

Posted by DreamHunter > 2021-05-27 22:52 | Report Abuse

sure boh

Posted by WinningBenning > 2021-05-27 23:41 | Report Abuse

Start to move up !

Posted by Riaz1954 > 2021-05-28 09:23 | Report Abuse

I agree of Sing is using this saliva based testing, no point reinventing the wheel...need to be quick off the Mark. Just like vaccines being approved by leading world scientists should me no need to detailed testing as much critical time is wasted. Time is of essence and cost lives and money

Posted by Riaz1954 > 2021-05-28 09:26 | Report Abuse

Time to be brave and innovative. uK gov after a disasterous handling of CV stumbled in right strategy, that is Funding vaccine development and deployment without much red tape! It was owned and driven by one lady and once good scientist ..Valance...saved the bacon for Incompetent Boris and cabinet.

Posted by OnTime > 2021-05-28 23:03 | Report Abuse

KUALA LUMPUR: The Health Ministry is prepared to consider approving breathalysers that can be used to detect Covid-19.

Health Minister Datuk Seri Dr Adham Baba said the Medical Device Authority (MDA) would allow applications by suppliers who intend to bring in devices, including Breathonix, which is currently used in Singapore.

"The use of these devices is something that has to be explored in Malaysia as it appears to be a much simpler (testing solution), but the MDA is still waiting for suppliers to submit their applications."

Reuters recently reported that Singapore had provisionally approved Breathonix, a breathalyser test that could detect whether a person was infected with the coronavirus in less than a minute...

https://www.msn.com/en-my/news/national/ministry-prepared-to-approve-covid-19-breathalysers/ar-AAKsDPN?ocid=msedgntp

Posted by RainT > 2021-05-29 23:27 | Report Abuse

buy

Posted by collie > 2021-05-31 11:42 | Report Abuse

very strong collection

Posted by spchia > 2021-05-31 20:49 | Report Abuse

Good financial result

Posted by Start_0f_the_bull > 2021-05-31 21:47 | Report Abuse

Div and bonus issue to be announced soon.

Posted by spchia > 2021-05-31 21:56 | Report Abuse

Wait on 3 June

Posted by Exnstp > 2021-05-31 22:40 | Report Abuse

Strong results!

Posted by bobochacha > 2021-05-31 23:28 | Report Abuse

the meeting postpone to 1st July due to MCO, wait longer for the bonus issue..

Posted by U1818 > 2021-06-01 08:48 | Report Abuse

EGM 3-6-2021 (11am)
AGM 1-7-2021 (10am)

Posted by Riaz1954 > 2021-06-01 09:41 | Report Abuse

Good consistent results ..yet price stable...the impact will filter through in few days.

Posted by scholez18 > 2021-06-01 11:54 | Report Abuse

"strong" and "good" financial results? very understated - i call it a monster performance.

41% revenue growth and 30% earnings growth yoy, guys. Let's call it what it is :)

Posted by OnTime > 2021-06-01 14:44 | Report Abuse

Well done, Myeg! Ah Wong buying?

Posted by bobochacha > 2021-06-01 18:45 | Report Abuse

i keep seeing the wrong date. must get my self a spectacle

Posted by bobochacha > 2021-06-01 18:46 | Report Abuse

so thursday EGM as usual..

Posted by Mr.Sm Invest123 > 2021-06-01 21:19 | Report Abuse

Date: 01/06/2021

Source : MACQUARIE GROUP
Macquarie Equities Research (MQ Research) maintained an Outperform rating on My E.G. Services (MYEG) following its strong 1Q21 revenue and profit, mainly contributed by the health screening tests and motorcycle road tax renewals. MQ research believes these will continue to record higher volumes with the rising Covid-19 cases and the reintroduction of total lockdown which takes effect today. MQ Research’s target price for MYEG is RM2.42, 25.4% higher than yesterday’s closing price of RM1.93.

Good results driven by testing volume and road tax renewals
MQ Research reiterates an Outperform recommendation on MYEG following 1Q21 results. 1Q21 profit came in at RM76mn, 26%/23% of MQ Research/street’s expectations. 1Q21 revenue/profit grew strongly at 41%/30% YoY due to an increase in Covid-19 health screening tests and higher-than-expected motorcycle road tax renewals, mitigating the decline from lower immigration services, i.e. permit renewals and job matching. Its online grocery service, BELI, was an added driver, as MYEG processed ~RM1mn in sales per month in 1Q21. MQ Research sees a 16% 20-24E profit compound annual growth rate (CAGR) providing upside to MYEG’s 19x 22E enterprise value/earnings before interest, taxes, depreciation and amortization (EV/EBITDA).

What MQ Research liked.
In-line with MQ Research’s expectations,
MQ Research expects Covid-19 testing volume to contribute positively to MYEG’s 1Q21 results from the pent-up demand of migrant workers’ testing. MQ Research believes that testing rate momentum is still high in 2Q21 as Malaysia is undergoing intensive testing amidst rising infection cases and a full lockdown reintroduction. The full lockdown should boost online road tax renewals for both motorcycles and cars based on what MQ Research saw last year.

What MQ Research didn’t like.
The pivot towards Covid-related services, which is a lower margin business compared to its e-government services business for road transports or immigration services, is evident from lower profit margins seen this quarter.

What’s interesting.
Recently, MYEG announced more initiatives related to its healthcare segment by signing a Memorandum of Understanding with Breathonix to introduce a rapid breath test system for Covid-19 screening in Malaysia. The same test has been approved in Singapore. While commercial details are scarce, MQ Research believe the estimated launch price for the test is ~RM60. MYEG will need to get the necessary approvals from the Ministry of Health to launch it in Malaysia.
12-month Target Price Methodology
MYEG MK: RM2.42 based on a discounted cash flow (DCF) methodology

Posted by trading2019 > 2021-06-02 15:25 | Report Abuse

So many enquiries of MyEG's Covid-19 breathalyzer lately. https://www.theedgemarkets.com/article/myeg-signs-mou-bring-covid19-breath-test-system-malaysia

Posted by Start_0f_the_bull > 2021-06-02 15:38 | Report Abuse

Approval granted by HM already? Or announcement soon?

Posted by collie > 2021-06-02 15:50 | Report Abuse

might take some time but it will slowly move up i think. once news out then sell.

Posted by CHLEONG888 > 2021-06-02 17:50 | Report Abuse

this is the safe counter to invest, TP RM2.40 within 2 months

Posted by Start_0f_the_bull > 2021-06-02 19:16 | Report Abuse

Usually bonus ex date announced share price will surge, why once news out then sell?

Posted by collie > 2021-06-03 01:29 | Report Abuse

play by ear, if price moves up further already towards target with no BI ex date announced yet probably some will take profit if news out for HM approval.

Posted by Atan311 > 2021-06-03 11:38 | Report Abuse

BEIJING, May 28 (Xinhua) -- A three-shot recombinant protein COVID-19 vaccine developed in China is now available in Beijing.

The vaccine (CHO Cells) was jointly developed by the Institute of Microbiology under the Chinese Academy of Sciences and Anhui Zhifei Longcom Biopharmaceutical Co. Ltd. Researchers from the institute have been receiving their first jabs in Beijing's Haidian District since Thursday.

China authorized the emergency use of the vaccine on March 10, and people from many provinces including Anhui and Hubei have since received the vaccine. On May 3, the first batch of the vaccine was rolled off the production line in Beijing, according to the institute.

The results of phase two trials, which involved people aged between 18 and 59, show that 83 percent of participants produced neutralizing antibodies after two doses of the vaccine, and 97 percent produced neutralizing antibodies after three doses.

The early-stage trials, conducted among people aged 60 and above, show that the seroconversion rate of neutralizing antibodies reached 95 percent after three doses, with no serious adverse reactions related to vaccination.

The level of neutralizing antibodies elicited by the vaccine is comparable to other recombinant protein COVID-19 vaccines and mRNA vaccines globally, the institute said in a statement.

Recombinant protein vaccines do not need to be produced in high-grade biosafety laboratories, and large-scale production can be quickly achieved. They are more cost-efficient and easier to store and transport, said the vaccine maker.

Dai Lianpan, a member of the vaccine development team and a researcher at the institute, said recombinant vaccine technology is mature and has been used for vaccines for several diseases such as hepatitis B and shingles.

The recommended interval between vaccine doses is one month.

"Two doses can produce neutralizing antibody levels slightly lower than those of recovered patients, but three doses will double the levels and produce a more lasting immune effect," said Dai, adding that the recombinant vaccine can induce stronger immune responses.

Researchers have tested the COVID-19 vaccine against a variant first detected in South Africa and found that the immune effect decreased slightly but antibody levels remained mostly effective.

Posted by Atan311 > 2021-06-03 11:40 | Report Abuse

(Global Times) -China continues to expand and accelerate nationwide inoculation with the launch of the country's first three-dose COVID-19 vaccine, which experts said would provide extra protection than the one-dose and two-dose candidates. The three-shot vaccine is already being administered in at least 13 provincial-level regions in China.

The three-dose COVID-19 vaccine was jointly developed by the Institute of Microbiology of Chinese Academy of Sciences (CAS) and Anhui Zhifei Longcom Biopharmaceutical. It is China's first, as well as the world's first recombinant subunit protein vaccine and it has already been approved by Chinese national authority, according to the website of the CAS microbiology institute.

Since being approved in China on March 10, the vaccine has been administered in at least 13 provincial-level regions in China, including East China's Anhui, Zhejiang, Jiangsu and Shandong provinces, Southwest China's Guizhou, Central China's Hubei and Henan provinces, as well as in Beijing, according to the institute's website and media reports

The company is expected to produce more than 500 million shots of the vaccine by the end of this year, the People's Daily reported on May 22.

Before approving the Zhifei Longcom vaccine, China had approved two-dose inactivated and one-dose recombinant adenovirus vector COVID-19 vaccines.

Compared with the others, the three-dose vaccine can provide more protection as its third dose can serve as a booster shot to enhance immunity, Tao Lina, a Shanghai-based vaccine expert, told Global Times on Sunday.

There have been signs that inoculated people will probably need a booster in the future. As China has put the epidemic under good control, it is unlikely that the country would provide booster shots to people in the near future. So people living in areas without epidemic can choose the Zhifei Longcom vaccine to get stronger protection although it may take a longer time to finish the procedure, Tao said.

According to the company website, it is better to administer the second and third shots of the Zhifei Longcom vaccine 28 and 56 days after the first injection.

As all five vaccines approved in the Chinese mainland are being rolled out on a more widespread scale, more people are rushing to get vaccinated given the recent cases of infections. China has continued to set records in its daily and overall vaccination numbers.

Posted by LossAversion > 2021-06-03 11:59 | Report Abuse

a potential growth shares that need to keep to see growth; not for trading.

Posted by FundaStronk > 2021-06-03 13:03 | Report Abuse

so today will announce bonus issue? since agm is today

Posted by Start_0f_the_bull > 2021-06-03 13:16 | Report Abuse

EGM or AGM?

Posted by Bunny69 > 2021-06-03 13:49 | Report Abuse

Today is EGM which is vote for bonus issue. While AGM is to vote for 1.7sen dividend which will held in July.
Mr wts today said the dividend will pay out first BEFORE bonus issue.

Posted by FundaStronk > 2021-06-03 14:35 | Report Abuse

my bad on the typo .. is EGM.. would we know whether bi is approved by today?

anyone attended the egm to know the result?

Posted by Bunny69 > 2021-06-03 15:13 | Report Abuse

Yes, is approved

Posted by tash1 > 2021-06-03 15:42 | Report Abuse

Bonusss approved !!!!!

Posted by Start_0f_the_bull > 2021-06-03 15:54 | Report Abuse

So announcement will be this evening I think.

Posted by Start_0f_the_bull > 2021-06-03 16:29 | Report Abuse

Explore what?

Posted by bobochacha > 2021-06-04 17:19 | Report Abuse

Awaiting further detail on the ex date. Must be 2 more week
Ah wong money comey come

Posted by Brucehwang > 2021-06-06 10:45 | Report Abuse

Myeg bonus matter is " free capital increase" for share holders? Any idea it's ratio?

Posted by tash1 > 2021-06-06 11:16 | Report Abuse

1:1 bonus